InterOcean Capital Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$844K Sell
15,564
-1,532
-9% -$78K 0.02% 235
2023
Q4
$877K Buy
17,096
+353
+2% +$18.5K 0.02% 215
2023
Q3
$972K Buy
16,743
+113
+0.7% +$6.92K 0.03% 188
2023
Q2
$1.06M Sell
16,630
-1,540
-8% -$103K 0.03% 173
2023
Q1
$1.26M Buy
18,170
+724
+4% +$51.1K 0.04% 157
2022
Q4
$1.26M Buy
17,446
+25
+0.1% +$1.89K 0.05% 159
2022
Q3
$1.24M Sell
17,421
-320
-2% -$23.2K 0.05% 147
2022
Q2
$1.37M Buy
17,741
+13,813
+352% +$1.05M 0.06% 137
2022
Q1
$287K Buy
3,928
+29
+0.7% +$1.95K 0.01% 220
2021
Q4
$243K Buy
+3,899
New +$229K 0.01% 233

Other funds holding BMY

InterOcean Capital Group's BMY Position: Q1 2024 in Review

InterOcean Capital Group reduced its Bristol-Myers Squibb (BMY) stake by 9% in Q1 2024, selling an estimated $78K and leaving 15,564 shares worth $844K. The position accounts for 0.02% of the portfolio, ranked #235.

InterOcean Capital Group first reported a position in BMY in Q4 2021 and has held it in 10 quarters since. The position peaked at $1.37M in Q2 2022. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • InterOcean Capital Group held 15,564 shares of Bristol-Myers Squibb worth $844K as of Q1 2024.
  • InterOcean Capital Group sold 1,532 Bristol-Myers Squibb shares in Q1 2024, an estimated $78K.
  • Bristol-Myers Squibb made up 0.02% of InterOcean Capital Group's portfolio in Q1 2024, its #235 holding.
  • InterOcean Capital Group first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 10 quarters since.
  • InterOcean Capital Group's Bristol-Myers Squibb position peaked at $1.37M in Q2 2022.
  • 2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on InterOcean Capital Group's 13F filing for Q1 2024, filed 13 May 2024.